Genmab | Reddito Netto

Prezzo Delle Azioni
1,791.50
Cambio Giornaliero
-33.50 -1.84%
Mensile
-10.34%
Annuale
12.85%
Q1 Previsione
1,806.42




Reddito Netto Cambiamento Data
Agios Pharmaceuticals USD -108.04M 4.61M 2025-12
Almirall EUR 26.58M 31.82M 2025-06
Amarin USD -7.74M 6.4M 2025-09
Amgen USD 1.33B 1.88B 2025-12
argenx SE USD 344.26M 98.9M 2025-09
AstraZeneca USD 2.33B 207M 2025-12
Bayer EUR -963M 764M 2025-09
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Demant DKK 427M 690M 2025-12
Exelixis USD 193.58M 8.73M 2025-09
Fresenius Medical Care EUR 274.8M 49.8M 2025-09
Galapagos EUR -202.11M 96.36M 2025-09
Genmab DKK 336M 141M 2025-06
GlaxoSmithKline GBP 636M 1.38B 2025-12
GN Store Nord DKK 344M 271M 2025-12
GRIFOLS EUR 126.96M 9.9M 2025-09
Hikma Pharmaceutical USD 119M 14M 2025-06
Insmed USD -328.48M 41.54M 2025-12
Lonza CHF 307M 22M 2024-12
Merck EUR 902M 250M 2025-09
Novartis USD 3.93B 96M 2025-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
UCB EUR 857M 649M 2024-12


Genmab Reddito Netto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.